THE NEED FOR NMN CLINICAL TRIALS In a recent post, we discussed a key barrier in our knowledge of NMN supplementation in humans - namely the very limited clinical trial data. However, this barrier is soon to be removed, thanks to high profile research + business collaborations which a directly confronting this lack of information. With their execution and success, we will soon have a clear understanding of the benefits of NMN supplementation in human subjects (well beyond simpler experimental results, such as how NMN improved our Founder Nick’s biological age by 3.5 years). COLLABORATIONS ON NMN CLINICAL RESEARCH One such collaboration we recently highlighted was the the work between aging research leader the Buck Institute, Elevant, and its parent...
Developed in collaboration with scientists at the Buck Institute for Research on Aging, the new product called Elevant Prime is formulated with nicotinamide mononucleotide (NMN). French entrepreneur Guillaume Bermond founded Seneque in 2018, and the company is focused on consumer products for NMN, including dietary supplements, cosmetics, and pets. The name ‘Seneque’ comes from Seneca the Younger, a Roman philosopher who encouraged people to discover vitality using their inner resources. READ FULL ARTICLE
Growing popularity for cellular health is not just coming from seniors intent on staying well as they age, but also from younger demographic groups who are looking to fortify their health in the years ahead. This is according to Guillaume Bermond, founder of Seneque, an international biotechnology company, discussing the latest trends surrounding nicotinamide mononucleotide (NMN) and cellular health with NutritionInsight. “We hear from people who usually take vitamin supplements telling us they are turning to [Seneque’s NMN supplements] looking for something that works at a cellular level to support health and well-being,” he says. READ FULL ARTICLE
Leading NAD+ scientist and the Chair of Seneque’s Scientific Advisory Board, Dr. Eric Verdin, discusses NMN research and the future of NAD+ boosters in this insightful interview with Longevity Blog. Dr. Verdin also shares his own personal approach to longevity, and what he thinks is the best and safest anti-aging medicine that we have today. READ FULL ARTICLE
NMN anti-aging research, NMN benefits and the future of NAD+ boosting Lifespan.io features Elevant Prime
Elevant Chief Scientist Dr. Alessia Grozio and company founder Guillaume Bermond discuss the technology behind Elevant, how NMN can impact the hallmarks of aging, and more in an illuminating interview with Lifespan.io. Lifespan.io is an international team of journalists, scientists, content creators, and other industry experts focused on aging research and promoting healthy human longevity through the development of rejuvenation biotechnology and regenerative medicine. READ FULL ARTICLE